SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

USFDA Concludes InvaGen Facility Inspection With Zero Observations

Cipla said the FDA completed a routine inspection at its InvaGen subsidiary’s New York facility with zero Form 483 observations.

CIPLA

Related stories